We are currently investigating experimental medications for Non-small cell lung cancer (NSCLC)
Non-small cell lung cancer (NSCLC) accounts for about 85–90% of Lung Cancer diagnoses and is composed of 3 subtypes: squamous cell (epidermoid) carcinoma, adenocarcinoma and large cell (undifferentiated) carcinoma.
Answer a few questions below to see if there are clinical trials that might be right for you.
Thank You for Considering a Clinical Trial
Below you will find research studies that are currently evaluating patients for participation. These are organized by Line of Therapy – which refers to the number of treatment options a patient has already received. Go to the Study Overview for more detailed information, including locations that are recruiting patients. You'll be guided through next steps.
Get updates on lung cancer clinical trials